Candida auris otomycosis in Iran and review of recent literature

Mahdi Abastabar1, Iman Haghani1, Fatemeh Ahangarkani1,2

  • 1Department of Medical Mycology/Invasive Fungi Research Center (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Mycoses
|December 27, 2018
PubMed

Insights

This study reports the first case of Candida auris otitis in Iran, a multidrug-resistant yeast. This finding highlights underdiagnosis challenges and expands the geographic surveillance of this emerging fungal pathogen.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Candida auris is a multidrug-resistant yeast with increasing global prevalence.
  • Identification challenges in resource-limited settings likely lead to underestimation of C. auris infections.
  • Otitis, or ear infection, is a less common but significant clinical presentation of C. auris.

Observation:

  • The first case of Candida auris otitis in Iran is reported, marking the fifth country in the Persian Gulf region affected.
  • The Iranian isolate belongs to the East-Asian clade, suggesting a potential link to otomycosis presentation.
  • Mycological and clinical data were compared with previously reported cases of C. auris otitis.

Findings:

  • Candida auris otitis represents a distinct clinical manifestation, particularly associated with the East-Asian clade.
  • Misdiagnosis of Candida species in routine Iranian laboratories may contribute to the underreporting of C. auris.
  • The geographic spread of C. auris in the Persian Gulf region is expanding.

Implications:

  • Increased awareness and improved diagnostic capabilities are crucial for timely detection and management of C. auris infections.
  • This case underscores the need for enhanced surveillance of emerging fungal pathogens in Iran and surrounding areas.
  • Understanding the clinical spectrum of C. auris, including otomycosis, is vital for effective public health strategies.